RxDoctor Payments Data

Kevin Oneal, MD

Family Medicine · Bogart, GANPI 1740218072

Payments from drug & device makers

$848in general payments, 2019–2025

Across 45 payments — averaging $18.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$210
  • Pfizer$198
  • Lilly USA, LLC$157
  • Boehringer Ingelheim$112
  • GSK$47
  • Sanofi Pasteur Inc.$27
  • plus $98 from 5 others

What the payments were for

  • Food & beverage$848100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$848 in reported general payments places this provider in the 55th percentile of 3,111 family medicine providers in Georgia.

See all family medicine providers in Georgia

Medicare billing

Part B allowed, 2024
$65,094
Medicare patients
118
Services billed
877

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$42,986
JanuviaSitagliptin Phosphate37$40,473
EliquisApixaban20$28,775
JanumetSitagliptin Phos/Metformin Hcl14$22,704
XareltoRivaroxaban15$20,940
Invokamet XrCanagliflozin/Metformin Hcl18$15,148
AbrysvoRsv Vacc, Pref A And Pref B/Pf44$13,905
InvokametCanagliflozin/Metformin Hcl12$13,651
ArexvyRsvpref3 Antigen/As01e/Pf26$7,916
LinzessLinaclotide11$7,273
Humalog Kwikpen U-100Insulin Lispro13$2,223
Gabapentin76$2,105
Pravastatin Sodium154$1,844
Amlodipine-OlmesartanAmlodipine Bes/Olmesartan Med22$1,810
Levothyroxine Sodium173$1,787

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Janumet$15$63,17751 claims
Novo NordiskOzempic$210$42,98632 claims
PfizerEliquis, Abrysvo$198$42,67964 claims
GSKArexvy$47$7,91626 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,111 family medicine providers in Georgia.

Other family medicine in Bogart

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →